Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

4 results about "Single-nucleotide polymorphism" patented technology

A single-nucleotide polymorphism (SNP; /snɪp/; plural /snɪps/) is a substitution of a single nucleotide that occurs at a specific position in the genome, where each variation is present at a level of <1% in the population.

Molecular marker related to feed conversion efficiency characters of meat ducks and application thereof

ActiveCN108165639AReduce manufacturing costSpeed up genetic progressMicrobiological testing/measurementDNA/RNA fragmentationSingle-nucleotide polymorphismZoology
The invention discloses a molecular marker related to the feed conversion efficiency character of meat ducks and application thereof. The invention provides a method for detecting the feed conversionefficiency characters of ducks to be detected. The method comprises the following steps: the genotype based on a specific SNP (Single Nucleotide Polymorphism) of the duck to be detected, the feed conversion efficiency of the AA genotype duck to be detected is higher than that of the AC genotype duck to be detected, and the feed conversion efficiency of the AC genotype duck to be detected is higherthan that of the CC genotype duck to be detected. On the basis of the genotype of the SNP site, the selection of the feed conversion efficiency characters can be realized, the feed conversion efficiency of the AA genotype duck is superior to that of the AC genotype duck and the CC genotype duck, and the feed conversion efficiency of the AC genotype duck is superior to that of the CC genotype duck. The molecular marker disclosed by the invention has the beneficial effects that early selection for the feed conversion efficiency characters can be realized, the production cost can be saved, the genetic progress can be accelerated, the breeding of the ducks can be better served and the economic application value and the scientific research are very large.
Owner:INST OF ANIMAL SCI CAAS

Methods and kits for predicting the risk of diabetes associated complications using genetic markers and arrays

InactiveUS20130209447A1Nucleotide librariesMicrobiological testing/measurementDiabetic kidneyGenetics predisposition
A method for diagnosing a genetic predisposition in a subject for diseases, disorders or conditions including a diabetic kidney complication such as kidney disease of type 2 diabetes or type 1 diabetes, end stage renal disease (ESRD) due to type 2 diabetes, ESRD due to hypertension in type 2 diabetes, ESRD due to type 1 diabetes; cardiovascular diseases due to type 2 diabetes or type 1 diabetes such as atherosclerotic peripheral vascular disease, hypertension, ischemic cardiomyopathy, and myocardial infarction due to type 2 diabetes or type 1 diabetes; and cerebrovascular accident due to type 2 diabetes. At least one polynucleotide is analyzed to detect a single nucleotide polymorphism (SNP), in which the presence of the single nucleotide polymorphism indicates that the subject is suffering from, at risk for, or suspected of suffering from the diseases, disorders or conditions. Also provided is an array or kit for diagnosing the genetic predisposition.
Owner:THE CHINESE UNIVERSITY OF HONG KONG

Method and device for detecting target gene or SNP (Single Nucleotide Polymorphism) site of target gene by combining asymmetric PCR (Polymerase Chain Reaction) and magnetic sensitive detector

PendingCN114107438AShort reaction timeSimple designBioreactor/fermenter combinationsBiological substance pretreatmentsHybridization reactionSingle strand
The invention discloses a method and a device for detecting a target gene or an SNP (Single Nucleotide Polymorphism) site of the target gene by combining asymmetric PCR (Polymerase Chain Reaction) with a magnetic sensitive detector. The method for detecting the gene marker by combining the asymmetric PCR with the magnetic sensitive detector comprises the following steps: (1) providing a biological sample and treating the biological sample; (2) carrying out asymmetric PCR (Polymerase Chain Reaction) amplification to obtain a single-chain gene marker with a biotin label; (3) hybridizing a single-chain gene marker, and combining the single-chain gene marker with the modified magnetic beads; and (4) detecting a signal through a magnetic sensitive detector. According to the method provided by the invention, the target gene can be directly amplified from the blood, special DNA extraction and purification are not needed, and the reaction time for obtaining the target gene from the blood can be shortened. The asymmetric PCR system provided by the invention can simultaneously amplify and detect a plurality of target genes, the target genes are single-stranded DNA with markers, the influence of complementary chains on the hybridization reaction of the capture probe is reduced, the single-stranded DNA is easy to hybridize and combine with the capture probe, and the intensity of an output signal is improved.
Owner:TDK CORPARATION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products